Taiko Expands OTC Market In China And Middle East
This article was originally published in PharmAsia News
Executive Summary
Amid a shrinking domestic demand for its major selling over-the-counter Seirogan, Taiko Pharmaceutical Co. Ltd is eyeing expansion in China and the Middle East.